ZA979411B - The use of lithium compounds for combatting human papilloma virus infections. - Google Patents
The use of lithium compounds for combatting human papilloma virus infections.Info
- Publication number
- ZA979411B ZA979411B ZA9709411A ZA979411A ZA979411B ZA 979411 B ZA979411 B ZA 979411B ZA 9709411 A ZA9709411 A ZA 9709411A ZA 979411 A ZA979411 A ZA 979411A ZA 979411 B ZA979411 B ZA 979411B
- Authority
- ZA
- South Africa
- Prior art keywords
- papilloma virus
- human papilloma
- virus infections
- lithium compounds
- combatting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9621990.2A GB9621990D0 (en) | 1996-10-22 | 1996-10-22 | Use |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA979411B true ZA979411B (en) | 1998-06-23 |
Family
ID=10801805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9709411A ZA979411B (en) | 1996-10-22 | 1997-10-21 | The use of lithium compounds for combatting human papilloma virus infections. |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU4715397A (en) |
GB (1) | GB9621990D0 (en) |
WO (1) | WO1998017288A1 (en) |
ZA (1) | ZA979411B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001030355A1 (en) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Contraceptive medicine based on a progestational agent and an oestrogen and preparation method |
SE513436C2 (en) | 1999-01-21 | 2000-09-11 | Astrid Agholme | Use of a formulation containing formic acid for the manufacture of a medicament for the treatment of warts, caused by Papillomavirus |
ES2164018B1 (en) * | 2000-05-26 | 2003-06-16 | Inst De Salud Carlos Iii | USE OF A LITHIUM SALT IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF THE INFECTION CAUSED BY THE HUMAN SYNTHETIC RESPIRATORY VIRUS (VRDH) |
US20040191207A1 (en) * | 2003-03-31 | 2004-09-30 | Lipari John M. | Alpha-hydroxy acid ester drug delivery compositions and methods of use |
US8048454B2 (en) | 2004-03-09 | 2011-11-01 | Michael Martin | Methods and compositions related to regulation of cytokine production by glycogen synthase kinase 3 (GSK-3) |
WO2016207366A1 (en) * | 2015-06-26 | 2016-12-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of viral infections |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3863678D1 (en) * | 1987-04-27 | 1991-08-22 | Efamol Holdings | PHARMACEUTICAL PREPARATIONS CONTAINING LITHIUM SALTS. |
-
1996
- 1996-10-22 GB GBGB9621990.2A patent/GB9621990D0/en active Pending
-
1997
- 1997-10-21 WO PCT/GB1997/002905 patent/WO1998017288A1/en active Application Filing
- 1997-10-21 ZA ZA9709411A patent/ZA979411B/en unknown
- 1997-10-21 AU AU47153/97A patent/AU4715397A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU4715397A (en) | 1998-05-15 |
WO1998017288A1 (en) | 1998-04-30 |
GB9621990D0 (en) | 1996-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA977807B (en) | New pharmaceutically active compounds. | |
ZA978639B (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin infections. | |
GB2341180A9 (en) | Compounds on the basis of polyalkyl-1-oxa diazaspirodecane compounds | |
NO986086D0 (en) | Process for the preparation of 17-esters of 9 <alpha>, 21-dihalo-pregnan-11 | |
ZA979411B (en) | The use of lithium compounds for combatting human papilloma virus infections. | |
AU2739497A (en) | Use of vitamin d analogs for the treatment of arthritic disease | |
ZA977809B (en) | New pharmaceutically active compounds. | |
GB9613360D0 (en) | Disposable pouch | |
HUP0000483A3 (en) | Use of aminoisothiazoles as microbicides | |
HUP9800032A3 (en) | 3-aryluracil-derivatives, preparation and use thereof, herbicidal compositions containing these compounds and preparation of the latest | |
GB9425796D0 (en) | The preparation of halogenated compounds | |
IL119744A (en) | Use of 8,9-dehydroestrone for the preparation of antioxidant medicaments | |
GB9415313D0 (en) | The preparation of organic compounds | |
HUP0004734A3 (en) | Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors | |
IT1283641B1 (en) | PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINE | |
ZA986324B (en) | Composition for the treatment of immunodeficiency disease | |
SG81238A1 (en) | Use of triphenylmethyl-1,2,3-triazoles | |
ZA956322B (en) | The preparation of organic compounds | |
GB9601042D0 (en) | Medical use | |
AU4581697A (en) | Walker | |
AU9359898A (en) | Use of moxonidine for the treatment of depression | |
GB9414973D0 (en) | The preparation of organic compounds | |
IL118651A0 (en) | Composition for the treatment of viral infections | |
ZA964250B (en) | 2-amino-benzoxazinones for the treatment of viral infections. | |
ITMI970682A1 (en) | PROCEDURE FOR THE PREPARATION OF (S) -N-TERBUTYL-1, 2, 3, 4- TETRAIDROISOCHINOLIN-3- CARBOXYAMIDE |